( NASDAQ-NMS:GRFS, SpanishCats:GRF, OTC-PINK:GIKLY, SpanishCats:GRF.P )

News from Grifols A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

23 May, 2017, 05:00 ET Grifols stellt Procleix Zika Virus Testkit bereit

- Grifols stärkt sein Procleix-Portfolio mit der CE-Kennzeichnung für Procleix Zika Virus Assay - Blutbanken in Ländern, die die CE-Kennzeichnung*...


23 May, 2017, 05:00 ET Grifols met à la disposition des pays exigeant des tests marqués CE le test Procleix Zika Virus Assay** pour le dépistage du virus Zika sur les dons de sang

- Grifols renforce sa gamme de tests Procleix® par le marquage CE du test Procleix® Zika Virus Assay - Les banques du sang dans les pays exigeant...


23 May, 2017, 05:00 ET Grifols pone a disposición de los países que aceptan la marca CE su prueba de detección en sangre del virus Zika

- Grifols refuerza su cartera de productos Procleix® con la Conformidad Europea para esta prueba - A partir de ahora, los bancos de sangre en...


09 May, 2017, 10:00 ET Investigational New Drug Application is Now Effective for Babesia Screening in Blood Donations Using Grifols Procleix Panther System in the US

- Test is designed to detect the presence in whole blood, of the four clinically relevant species of Babesia (B. microti, B. duncani, B....


24 Apr, 2017, 08:00 ET Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility

Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS), a global healthcare company with a history of more than 75 years of improving people's health and...


17 Apr, 2017, 09:00 ET Grifols fait un don de 140 millions d'UI de facteurs de coagulation au Programme d'aide humanitaire de la Fédération mondiale de l'hémophilie

Contribution au traitement de dizaines de milliers de patients dans les pays en développement, renouvellement du partenariat avec la FMH et...


17 Apr, 2017, 09:00 ET A Grifols Doa 140 Milhões de Unidades Internacionais de Fatores da Coagulação Sanguínea ao Programa de Ajuda Humanitária da Federação Mundial de Hemofilia

Ajudar a tratar dezenas de milhares de doentes em países em desenvolvimento; renovar a parceria com a WFH; reafirmar o compromisso de melhorar as...


17 Apr, 2017, 09:00 ET Grifols Donates 140 Million International Units of Blood Clotting Factors to the World Federation of Hemophilia Humanitarian Aid Program

Helping treat tens-of-thousands of patients in developing countries; renewing partnership with WFH; reaffirming commitment to improving the lives...


17 Apr, 2017, 09:00 ET Grifols dona 140 millones de unidades de factor de coagulación al Programa de Ayuda Humanitaria de la Federación Mundial de Hemofilia

La compañía renueva su colaboración con la FMH, reafirma su compromiso de mejorar la vida de los pacientes de todo el mundo y ayuda para que miles...


17 Apr, 2017, 09:00 ET Grifols dona farmaci a base di fattori coagulanti per 140 milioni di unità internazionali al programma di aiuti umanitari della World Federation of Hemophilia

Contribuire alla cura di decine di migliaia di pazienti nei paesi in via di sviluppo; rinnovata la partnership con la WFH; ribadito l'impegno a...


17 Apr, 2017, 09:00 ET A Grifols Doa 140 Milhões de Unidades Internacionais de Fatores da Coagulação Sanguínea ao Programa de Ajuda Humanitária da Federação Mundial de Hemofilia

Ajudar a tratar dezenas de milhares de doentes em países em desenvolvimento; renovar a parceria com a WFH; reafirmar o compromisso de melhorar as...


17 Apr, 2017, 09:00 ET Grifols spendet 140 Millionen Internationale Einheiten von Blutgerinnungsfaktoren an das Humanitarian Aid Program der World Federation of Hemophilia

- Unterstützung hilft bei der Behandlung von Zehntausenden von Patienten in Entwicklungsländern - Verlängerung der Partnerschaft mit der World...


04 Apr, 2017, 09:11 ET Grifols 2016 Annual Report on Form 20-F filed with the SEC on April 4, 2017

Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) announced that it has filed its 2016 Annual Report on Form 20-F with the United...


31 Jan, 2017, 16:05 ET Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million

The company consolidates a leading position of its Diagnostic Division enhancing its integration - Grifols completes in record time the...


14 Dec, 2016, 16:15 ET Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million

- Grifols entered into an agreement to acquire Hologic's (Nasdaq: HOLX) interest in their existing joint-business under which Grifols...


05 Sep, 2016, 05:33 ET Grifols Opens Diagnostic Training Center in Dubai

BARCELONA, Spain, Sept. 5, 2016 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS),  a global healthcare company with more than...


14 May, 2014, 05:23 ET Grifols verkündet die Verfügbarkeit des AlphaKit® QuickScreen, eines neuartigen Point-of-Care Screening Tests zur Unterstützung beim Auschluss von Alpha-1-Antitrypsin Mangel (AATM)

- AlphaKit® QuickScreen ist ein neuartiger, immun-chromatographischer, in-vitro diagnostischer Screening Test auf die Z-Form des...


12 Nov, 2013, 08:08 ET Grifols va acquérir les activités diagnostiques de Novartis pour 1 675 millions de dollars

- Les actifs acquis comprennent des produits de diagnostic in vitro et une technologie de médicine et d'immunologie transfusionnelle, une unité de...


11 Nov, 2013, 02:18 ET Grifols to acquire a Novartis diagnostics business unit for US$1,675 million

- The assets acquired include in vitro diagnostic products and technology for transfusion medicine and immunology, a manufacturing plant...


09 Sep, 2013, 17:03 ET Grifols verkündet Gewinner des 10. jährlichen Forschungsstipendiums eALTA beim ERS-Kongress 2013

- Die Stipendien finanzieren Forschung aus beginnenden Forschungskarrieren zur Förderung des Verständnisses und der Behandlung des...


09 Sep, 2013, 12:46 ET Grifols introduce l'AlphaKit® QuickScreen, un nuovo dispositivo per lo screening point-of-care per rilevare il deficit di alfa1-antitripsina (AAT), una delle cause principali di enfisema / COPD genetico negli adulti

- Dettagli presentati al congresso annuale della European Respiratory Society (ERS) Grifols, una società mondiale operante nel settore...


09 Sep, 2013, 12:39 ET Grifols annuncia i vincitori della decima borsa di ricerca eALTA nel corso del Congresso ERS 2013

- I premi finanziano la ricerca da parte di giovani sperimentatori per una maggiore conoscenza del deficit di alfa1-antitripsina e delle relative...


09 Sep, 2013, 03:00 ET Grifols stellt den AlphaKit® QuickScreen vor, ein neuartiges Gerät zur Untersuchung am Pflegeort und zur Identifizierung von Alpha1-Antitrypsin (AAT) Mangel, eine der Hauptursachen von genetischem Emphysem / COPD in Erwachsenen

-- Details wurden auf der Jahrestagung der Europäischen Gesellschaft für Atemwegserkrankungen (ERS) veröffentlicht Grifols, ein globales...


12 Aug, 2013, 14:11 ET California State Legislature recognizes Grifols for its Decennial Anniversary in California

 Today Grifols was honored at the California State Legislature by state Senator Kevin de Leon (D-Los Angeles) and Assembly Member Jimmy...


18 Jul, 2013, 08:47 ET Grifols implemetiert erstes automatisiertes Karussellsystem für das Bestandmanagement von Prüfpräparaten an der Emory University

 Grifols, ein globales medizinisches Unternehmen mit Sitz in Barcelona, Spanien, und über 15 Jahren an Innovations- und Betriebserfahrung...